Treatment as prevention – free webinar

Gus Cairns
Published: 20 March 2013

As part of its European HIV prevention work, NAM is collaborating with AVAC to provide a series of webinars (conference calls with accompanying slides) to train and inform prevention advocates and anyone interested in the newest developments in HIV prevention technology.

The next webinar is on HIV treatment as prevention in Europe.

This 90-minute webinar will examine treatment as prevention, the influence of treatment guidelines and whether antiretroviral therapy is starting to curb the HIV epidemic in Europe. The presentations will be followed by a question and answer session with our expert speakers. The webinar will be conducted in English.

Time and date: 2pm UK time (GMT), Thursday 28 March (3pm CET)

To register for the webinar and get phone numbers and joining instructions click this link:

The webinar will feature presentations by:

  • Dr Valerie Delpech from the UK’s Health Protection Agency (HPA). Valerie is a public health consultant epidemiologist at the HPA and has been the lead on national surveillance of HIV infections for the UK for the past 6 years. She trained in medicine and public health in Australia and the UK and has extensive experience in communicable disease control and public health, with a particular interest in sexual health and health inequalities.
  • Virginie Supervie from INSERM in France. Virginie is a post-doctoral fellow at INSERM (Institut National de la Santé et de la Recherche Médicale) Paris in the unit of clinical epidemiology, therapeutic strategies and virology in HIV infection directed by Dr Dominique Costagliola. She uses the tools of statistical and mathematical sciences and epidemiology to address public health issues raised by HIV.
  • Brian West, Chair of the European AIDS Treatment Group (EATG). Brian is a 55-year-old gay man, who has been living with HIV for 29 years and involved in the HIV sector for the past 20 years. He works in Scotland – but also in the rest of the UK. Over the last few years, his work has had more of a European focus through the EATG, where he is currently the Chair.

The discussion will be moderated and will also feature a presentation by Gus Cairns. Gus is a writer at NAM, where he edits HIV treatment update and Preventing HIV. He also edits the HIV prevention news: Europe bulletin as part of NAM’s programme of European prevention advocacy.

European advocates interested in learning more about HIV treatment as prevention are encouraged to join this webinar and to email questions in advance to During the event, participants will be encouraged to ask questions via telephone.

This project has been supported via a grant from Gilead Sciences Europe Ltd.

Gilead Sciences Europe Ltd has provided funding for this project and has had no editorial control over the content of the materials.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.